by Zainab Shahid, MD
ASTCT’s Transplant Infectious Disease (ID) Special Interest Group (SIG) has curated a track of sessions at this year’s Tandem Meetings. Sessions center around the latest in protecting...
by Alex Kadhim
Researchers from the European Society for Blood and Marrow Transplantation (EBMT) have found that using posttransplant cyclophosphamide (ptCy) for graft-versus-host disease (GVHD) prophylaxis in...
by Alex Kadhim
Researchers at Roswell Park Comprehensive Cancer Center and the University of Minnesota have found that targeting the pentose phosphate pathway (PPP) in donor T cells can significantly reduce the...
by Alex Kadhim
Researchers at McMaster University, collaborating with the Ottawa Hospital Research Institute, have found that a paired vaccine plus CAR strategy can broadly boost adoptively transferred T cells...
by Alex Khadhim
Researchers at University Hospital of Leipzig and Memorial Sloan Kettering Cancer Center have demonstrated that the BCMA CAR T product ciltacabtagene autoleucel appears to deliver deeper and...
by David Porter
In his last message as ASTCT President, David Porter, MD, highlights how his successes in 2025 were a shared effort, made possible by the ASTCT Board, staff, and members. He reflects on key...